UBRELVY
Active substance: ubrogepant
TABLET · UBROGEPANT 50 mg/1
United StatesActive
Marketing holder: Allergan, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- UBROGEPANT · 50 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-41c6-7cbe-be7e-5d2755804e07,01a12091-d99f-7643-a21c-9a6c756eb41a,01a12097-be10-7dc1-ae4e-6f1bc44e79b4,01a12098-cd00-7f1b-86b8-e164f6b9da1c;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0023-6498
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0023-6498 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0023-6498 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0023-6498 · Verified 2026-10-09 · open in source